Published in Diabetes Metab on November 01, 2003
Cardiovascular risk prediction is improved by adding asymptomatic coronary status to routine risk assessment in type 2 diabetic patients. Diabetes Care (2011) 0.86
Atherogenic dyslipidemia and risk of silent coronary artery disease in asymptomatic patients with type 2 diabetes: a cross-sectional study. Cardiovasc Diabetol (2016) 0.84
Prevalence of symptomatic and silent stress-induced perfusion defects in diabetic patients with suspected coronary artery disease referred for myocardial perfusion scintigraphy. Eur J Nucl Med Mol Imaging (2004) 0.81
Asymptomatic coronary heart disease in patients with type 2 diabetes with vascular complications: a cross-sectional study. BMJ Open (2011) 0.81
Glycation gap is associated with macroproteinuria but not with other complications in patients with type 2 diabetes. Diabetes Care (2013) 0.79
Flow-mediated-paradoxical vasoconstriction is independently associated with asymptomatic myocardial ischemia and coronary artery disease in type 2 diabetic patients. Cardiovasc Diabetol (2014) 0.77
Type 1 diabetes: Developing the first risk-estimation model for predicting silent myocardial ischemia. The potential role of insulin resistance. PLoS One (2017) 0.75
The clinical significance of continuous ECG (ambulatory ECG or Holter) monitoring of the ST-segment to evaluate ischemia: a review. Prog Cardiovasc Dis (2013) 0.75
A Case of Transient ST Elevation and Polymorphic Tachycardia without Angina Diagnosed by Holter Monitoring. Cureus (2017) 0.75
A European evidence-based guideline for the prevention of type 2 diabetes. Horm Metab Res (2010) 3.15
Low dose methotrexate osteopathy in a patient with polyarticular juvenile idiopathic arthritis. Ann Rheum Dis (2003) 2.23
Take action to prevent diabetes--the IMAGE toolkit for the prevention of type 2 diabetes in Europe. Horm Metab Res (2010) 1.99
Neanderthal cannibalism at Moula-Guercy, Ardèche, France. Science (1999) 1.66
Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent myocardial ischemia. Diabetes Care (2001) 1.53
Cardiac autonomic neuropathy in diabetic patients: influence of diabetes duration, obesity, and microangiopathic complications--the French multicenter study. Metabolism (2003) 1.52
[Arterial hypertension and diabetes. Members of the Board of Directors and Scientific Directors of ALFEDIAM]. Diabetes Metab (1996) 1.50
Consensus statement on the care of the hyperglycaemic/diabetic patient during and in the immediate follow-up of acute coronary syndrome. Arch Cardiovasc Dis (2012) 1.42
CD4 lymphopenia in elderly patients. Lancet (1996) 1.40
Lamin A/C gene: sex-determined expression of mutations in Dunnigan-type familial partial lipodystrophy and absence of coding mutations in congenital and acquired generalized lipoatrophy. Diabetes (2000) 1.17
High prevalence of serum antibodies to hepatitis C virus in patients with Hashimoto's thyroiditis. BMJ (1994) 1.16
A review of the metabolic syndrome. Diabetes Metab (2007) 1.12
High prevalence of diabetes mellitus in patients with chronic hepatitis C. A case-control study. Gastroenterol Clin Biol (1996) 1.11
Mesangio-capillary glomerulonephritis and the nephrotic syndrome in the course of disseminated tuberculosis. Nephron (1988) 1.01
Effect of psyllium on gastric emptying, hunger feeling and food intake in normal volunteers: a double blind study. Eur J Clin Nutr (1998) 1.01
Sacral insufficiency fractures: an easily overlooked cause of back pain in elderly women. Arch Intern Med (1996) 1.00
Microalbuminuria in obese patients with or without hypertension. Int J Obes Relat Metab Disord (1996) 0.99
Reversibility by dipyridamole of thallium-201 myocardial scan defects in patients with sarcoidosis. Am J Med (1988) 0.99
Association between cardiac autonomic neuropathy and hypertension and its potential influence on diabetic complications. Diabet Med (2010) 0.97
Quality indicators for the prevention of type 2 diabetes in Europe--IMAGE. Horm Metab Res (2010) 0.97
Fas/Fas-Ligand pathway is impaired in patients with type 2 diabetes. Influence of hypertension and insulin resistance. Diabetes Metab (2005) 0.97
Identification of myocardial ischemia in the diabetic patient. Joint ALFEDIAM and SFC recommendations. Diabetes Metab (2004) 0.97
Erythrocyte deformability in diabetes and erythrocyte membrane lipid composition. Metabolism (1990) 0.96
Diabetic peripheral neuropathy: effects of age, duration of diabetes, glycemic control, and vascular factors. J Diabetes Complications (1997) 0.94
Comparative effects of diabetes mellitus and hypertension on physical properties of human large arteries. J Am Coll Cardiol (1992) 0.94
Intensification to biphasic insulin aspart 30/70 (BIAsp 30, NovoMix 30) can improve glycaemic control in patients treated with basal insulins: a subgroup analysis of the IMPROVE observational study. Int J Clin Pract (2009) 0.93
Phenformin-induced lactic acidosis in diabetic patients. Diabetes (1975) 0.93
Elevated concentrations of soluble E-selectin and vascular cell adhesion molecule-1 in NIDDM. Effect of intensive insulin treatment. Diabetes Care (1998) 0.92
A simple new non-invasive sweat indicator test for the diagnosis of diabetic neuropathy. Diabet Med (2013) 0.92
Reproducibility of parameters for assessment of diabetic neuropathy. The French Group for Research and Study of Diabetic Neuropathy. Diabet Med (1993) 0.91
Prevalence and significance of left ventricular filling abnormalities determined by Doppler echocardiography in young type I (insulin-dependent) diabetic patients. Am J Cardiol (1989) 0.91
Diabetic neuropathy in elderly patients. What can be done? Drugs Aging (1996) 0.91
[Beliefs in diabetics about the etiology of their disease. Influence of ethnicity]. Diabete Metab (1990) 0.91
Laparoscopic ultrasonography is a complement to cholangiography for the detection of choledocholithiasis at laparoscopic cholecystectomy. Br J Surg (2002) 0.90
Feminizing Leydig cell tumor: endocrine and incubation studies. J Endocrinol Invest (1987) 0.90
Randomized study of glibenclamide versus traditional Chinese treatment in type 2 diabetic patients. Chinese-French Scientific Committee for the Study of Diabetes. Diabete Metab (1995) 0.90
Fluorocholine (18F) and sodium fluoride (18F) PET/CT in the detection of prostate cancer: prospective comparison of diagnostic performance determined by masked reading. Q J Nucl Med Mol Imaging (2011) 0.90
B-type natriuretic peptide, a marker of asymptomatic left ventricular dysfunction in type 2 diabetic patients. Diabetes Metab (2008) 0.90
Universal rather than selective screening for gestational diabetes mellitus may improve fetal outcomes. Diabetes Metab (2006) 0.89
Impairment of coronary microvascular dilation in response to cold pressor--induced sympathetic stimulation in type 2 diabetic patients with abnormal stress thallium imaging. Diabetes (2001) 0.89
Diagnosis of bone metastasis: recent comparative studies of imaging modalities. Q J Nucl Med Mol Imaging (2011) 0.89
Factors involved in cardiac autonomic neuropathy in diabetic patients. J Diabetes Complications (1997) 0.88
Safety and effectiveness of biphasic insulin aspart 30/70 (NovoMix 30) when switching from human premix insulin in patients with type 2 diabetes: subgroup analysis from the 6-month IMPROVE observational study. Int J Clin Pract (2009) 0.88
An economic evaluation of the cost of diabetic foot ulcers: results of a retrospective study on 239 patients. Diabetes Metab (2003) 0.88
High prevalence and severity of cardiac autonomic neuropathy in Vietnamese diabetic patients. Diabet Med (2005) 0.88
Cytochrome P450 2E1 activity in diabetic and obese patients as assessed by chlorzoxazone hydroxylation. Fundam Clin Pharmacol (1998) 0.88
Cetilistat (ATL-962), a novel lipase inhibitor: a 12-week randomized, placebo-controlled study of weight reduction in obese patients. Int J Obes (Lond) (2006) 0.88
Arterial hypertension in overweight and obese Algerian adolescents: role of abdominal adiposity. Diabetes Metab (2011) 0.88
[Bone marrow reconversion and magnetic resonance imaging: case report]. Rev Med Interne (2003) 0.86
Lower-limb vascularization in diabetic patients. Assessment by thallium-201 scanning coupled with exercise myocardial scintigraphy. Diabetes Care (2001) 0.86
Continuous glucose profiles with vildagliptin versus sitagliptin in add-on to metformin: results from the randomized Optima study. Diabetes Metab (2012) 0.86
Gonadal and adrenal catheterization during adrenal suppression and gonadal stimulation in a patient with bilateral testicular tumors and congenital adrenal hyperplasia. J Clin Endocrinol Metab (1994) 0.85
Effects of candesartan cilexetil on carotid remodeling in hypertensive diabetic patients: the MITEC study. Vasc Health Risk Manag (2009) 0.85
Ultradian, circadian and seasonal variations of plasma progesterone and LH concentrations during the luteal phase. Chronobiol Int (1989) 0.85
Effect of erythropoietin on bone marrow uptake of 18F-fluorocholine in prostate cancer: comparison with 18F-fluoride uptake. Clin Nucl Med (2013) 0.85
N-terminal pro-B-type natriuretic peptide: an independent marker for coronary artery disease in asymptomatic diabetic patients. Diabet Med (2009) 0.85
The report of male gender and retinopathy status improves the current consensus guidelines for the screening of myocardial ischemia in asymptomatic type 2 diabetic patients. Nutr Metab Cardiovasc Dis (2012) 0.84
Nutritional status after short-term dietary supplementation in hospitalized malnourished geriatric patients. Clin Nutr (2001) 0.84
Treatment of reflex sympathetic dystrophy with pamidronate: 29 cases. Rheumatology (Oxford) (2001) 0.84
Detecting silent coronary stenoses and stratifying cardiac risk in patients with diabetes: ECG stress test or exercise myocardial scintigraphy? Diabet Med (2004) 0.84
Arterial stiffness and the autonomic nervous system during the development of Zucker diabetic fatty rats. Diabetes Metab (2009) 0.83
Adrenocorticotropin-producing pituitary carcinoma with liver metastasis. J Endocrinol Invest (1997) 0.83
Short-term effects of continuous subcutaneous insulin infusion treatment on insulin secretion in non-insulin-dependent overweight patients with poor glycaemic control despite maximal oral anti-diabetic treatment. Diabetes Metab (1997) 0.83
Pressure-heart rate responses to alpha-adrenergic stimulation and hormonal regulation in normotensive patients with obstructive sleep apnea. Am J Hypertens (1997) 0.82
Management strategies for gastrointestinal, erectile, bladder, and sudomotor dysfunction in patients with diabetes. Diabetes Metab Res Rev (2011) 0.82
What would be the outcome if the American Diabetes Association recommendations of 2010 had been followed in our practice in 1998-2006? Diabet Med (2011) 0.82
Endocrine investigations in two cases of feminizing Leydig cell tumour. Acta Endocrinol (Copenh) (1987) 0.82
Hyperinsulinemia and hypofibrinolysis: effects of short-term optimized glycemic control with continuous insulin infusion in type II diabetic patients. Metabolism (1997) 0.81
Diphasic glucagon release induced by arginine in the perfused rat pancreas. Nat New Biol (1972) 0.81
Silent myocardial ischaemia and left ventricle hypertrophy in diabetic patients. Diabetes Metab (1997) 0.81